Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Deepak Sudheendra

Vascular & Interventional Radiology Dublin, OH Medical Doctor

NPI 1427138874 CMS profile 689104

6790 Perimeter Dr Ste 200, Dublin, OH 43016

Open in the dashboard

General payments

$57,117

179 records reported · program years 2019–2025

Research payments

$2,315

Paid to them · 2 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,050 paid to institutions, not to them · program year 2023

Through program year 2025, Deepak Sudheendra of Dublin, OH is reported in the CMS Open Payments database as having received $57,117 across 179 general payments and $2,315 in research payments paid to them. Separately, studies naming them as principal investigator received $1,050 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 91st percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $738 20
2024 General $1,552 11
2023 General $6,206 39
2023 Research $2,315 2
2022 General $6,258 29
2021 General $10,312 24
2020 General $6,539 5
2019 General $25,512 51

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Deepak Sudheendra
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Deepak Sudheendra were reported at $738. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Deepak Sudheendra Vascular & Interventional Radiology median Middle half National median
2019 $25,512 $422 $125–$1,555 $163
2020 $6,539 $200 $68–$652 $114
2021 $10,312 $280 $99–$866 $132
2022 $6,258 $433 $137–$1,497 $149
2023 $6,206 $506 $152–$2,019 $160
2024 $1,552 $556 $175–$1,930 $164
2025 $738 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $30,071 65 payments
  2. Sirtex Medical Inc $10,185 11 payments
  3. Siemens Medical Solutions USA, Inc. $6,826 22 payments
  4. Medtronic, Inc. $6,113 22 payments
  5. Philips Electronics North America Corporation $1,491 11 payments
  6. Cordis US Corp. $646 13 payments
  7. Asahi Intecc USA, Inc. $450 1 payment
  8. Inari Medical, Inc. $422 2 payments
  9. Becton, Dickinson and Company $265 9 payments
  10. Cardiovascular Systems Inc. $159 2 payments
  11. Other $489 21 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $32,695 12 payments
  2. Consulting Fee $10,030 8 payments
  3. Travel and Lodging $8,034 43 payments
  4. Food and Beverage $6,357 116 payments
Products named General payments · program years 2019–2025
  1. ANGIOJET Angioplasty $12,475 16 payments
  2. SIR-Spheres Microspheres $10,185 11 payments
  3. AngioJet AngioJet_PI $5,717 5 payments
  4. HawkOne $4,074 5 payments
  5. General Therapies Therapies $3,041 3 payments
  6. GENERAL - METALLIC STENTS $3,000 1 payment
  7. GENERAL THERAPIES General Therapies $1,642 11 payments
  8. ANGIOJET Pain Management $1,251 6 payments
  9. GENERAL PAIN MANAGEMENT $1,095 5 payments
  10. WALLSTENT $1,000 1 payment
  11. Other $8,500 101 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Asahi Intecc USA, Inc. $2,315 2 payments

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

22

Median for Interventional Radiology: 38

Drug cost

$22,548

Median for Interventional Radiology: $333

Branded share of claims

100%

Median for Interventional Radiology: 53%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 22 $22,548

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 554 Part D prescribers listed as Interventional Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 41 billing codes

Paid by Medicare

$113,806

Medicare's payments for the services billed

Medicare patients

60

Average age 73

Services billed

959

38 women, 22 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 68%
Ischemic heart disease 33%
Diabetes 28%
Depression 25%
Osteoporosis 23%
Chronic kidney disease 22%
Cancer 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

181 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record